Figure 1: Conversion of the monomeric HisPrP(90–231) to an oligomeric form by a redox process. Figure 4: Partial proteinase K (PK) resistance of HisPrP RDX (23–231). Figure 6: Speculative model for ...
The bacterial host Escherichia coli provides an attractive industrial protein production approach in terms of time and cost efficiency. Microbial production technology is straight forward, safe, and ...
Recent successes of recombinant proteins as therapeutics have greatly increased the number of companies developing such therapies. However, protein therapeutics and vaccines are frequently difficult ...
Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease 2019 (COVID-19) pandemic has placed a significant burden on healthcare systems across the globe. To ...
Recombinant antibodies (rAbs), also called genetically engineered antibodies, are produced by cloning the antibody which is made of light and heavy chain DNA sequences. In comparison to monoclonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback